Advanced Medical Solutions Group (LON:AMS) Price Target Raised to GBX 300 at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS) had its price objective boosted by Berenberg Bank from GBX 290 ($3.66) to GBX 300 ($3.79) in a report published on Wednesday, Marketbeat.com reports. The brokerage currently has a buy rating on the stock.

Advanced Medical Solutions Group Stock Up 2.9 %

Shares of LON AMS traded up GBX 5.60 ($0.07) during mid-day trading on Wednesday, reaching GBX 195.60 ($2.47). The company had a trading volume of 580,135 shares, compared to its average volume of 409,193. The stock has a fifty day moving average of GBX 205.42 and a two-hundred day moving average of GBX 202.15. The company has a debt-to-equity ratio of 3.74, a quick ratio of 4.58 and a current ratio of 5.67. The company has a market capitalization of £425.10 million, a price-to-earnings ratio of 2,796.80, a PEG ratio of 5.00 and a beta of 0.58. Advanced Medical Solutions Group has a 12-month low of GBX 165.60 ($2.09) and a 12-month high of GBX 261 ($3.30).

Advanced Medical Solutions Group Increases Dividend

The business also recently declared a dividend, which will be paid on Friday, June 21st. Stockholders of record on Thursday, May 30th will be given a GBX 1.66 ($0.02) dividend. This represents a dividend yield of 0.79%. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.70. The ex-dividend date is Thursday, May 30th. Advanced Medical Solutions Group’s dividend payout ratio is 2,857.14%.

Insider Activity at Advanced Medical Solutions Group

In other Advanced Medical Solutions Group news, insider Eddie Johnson acquired 27,051 shares of the business’s stock in a transaction that occurred on Friday, March 15th. The shares were purchased at an average price of GBX 192 ($2.43) per share, with a total value of £51,937.92 ($65,636.19). Insiders own 2.70% of the company’s stock.

Advanced Medical Solutions Group Company Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.